Upasana Arora
Sun, JK, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Sinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity.
Journal: Scientific reports
Published: November 17, 2022
Cocculus hirsutus-Derived Phytopharmaceutical Drug Has Potent Anti-dengue Activity.
Journal: Frontiers in microbiology
Published: July 23, 2021
Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement.
Journal: EBioMedicine
Published: April 28, 2019
Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation.
Journal: Pathogens and disease
Published: January 18, 2019
Next generation designer virus-like particle vaccines for dengue.
Journal: Expert review of vaccines
Published: December 28, 2018
Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice.
Journal: Scientific reports
Published: February 06, 2018
Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo.
Journal: Frontiers in microbiology
Published: October 24, 2017
A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.
Journal: PLoS neglected tropical diseases
Published: August 31, 2017
Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.
Journal: The American journal of tropical medicine and hygiene
Published: June 20, 2016
Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
Journal: BMC biotechnology
Published: March 21, 2016
Last Updated: 09/26/2026